AAAAAA

   
Results: 1-12 |
Results: 12

Authors: TUCKER MA MURRAY N SHAW EG ETTINGER DS MABRY M HUBER MH FELD R SHEPHERD FA JOHNSON DH GRANT SC AISNER J JOHNSON BE
Citation: Ma. Tucker et al., 2ND PRIMARY CANCERS RELATED TO SMOKING AND TREATMENT OF SMALL-CELL LUNG-CANCER, Journal of the National Cancer Institute, 89(23), 1997, pp. 1782-1788

Authors: HUBER MH LEE JS NEWMAN RA FOSSELLA FV WESTER M HONG WK LIPPMAN SM
Citation: Mh. Huber et al., A PHASE-I INVESTIGATION OF THE SEQUENTIAL USE OF METHOTREXATE AND PACLITAXEL WITH AND WITHOUT G-CSF FOR THE TREATMENT OF SOLID TUMORS, Annals of oncology, 7(1), 1996, pp. 59-63

Authors: PEREZSOLER R FOSSELLA FV GLISSON BS LEE JS MURPHY WK SHIN DM KEMP BL LEE JJ KANE J ROBINSON RA LIPPMAN SM KURIE JM HUBER MH RABER MN HONG WK
Citation: R. Perezsoler et al., PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER PREVIOUSLY UNTREATED WITH CHEMOTHERAPY, Journal of clinical oncology, 14(2), 1996, pp. 503-513

Authors: HUBER MH LIPPMAN SM BENNER SE SHIRINIAN M DIMERY IW DUNNINGTON JS HONG WK
Citation: Mh. Huber et al., A PHASE-II STUDY OF IFOSFAMIDE IN RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, American journal of clinical oncology, 19(4), 1996, pp. 379-383

Authors: HUBER MH LIPPMAN SM BENNER SE SHIRINIAN M DIMERY IW EARLY CL WINN RJ BROOKS J BAEZ L HONG WK
Citation: Mh. Huber et al., PHASE-II STUDY OF CARBOPLATIN AND CONTINUOUS-INFUSION BLEOMYCIN FOLLOWED BY CISPLATIN AND 5-FLUOROURACIL IN RECURRENT HEAD AND NECK-CANCER, Annals of oncology, 6(1), 1995, pp. 83-85

Authors: BENNER SE LIPPMAN SM HUBER MH HONG WK
Citation: Se. Benner et al., PHASE-I STUDY OF PACLITAXEL, CISPLATIN, AND IFOSFAMIDE IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CANCER OF THE HEAD AND NECK, Seminars in oncology, 22(5), 1995, pp. 22-25

Authors: HUBER MH DIMERY IW BENNER SE LIPPMAN SM SHIRINIAN M ESPARAZ B FRENNING D GUILLORYPEREZ C HONG WK
Citation: Mh. Huber et al., PHASE-II STUDY OF CARBOPLATIN AND EDATREXATE (10-EDAM) WITH LEUCOVORIN RESCUE FOR PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Investigational new drugs, 12(4), 1994, pp. 327-331

Authors: HUBER MH SHIRINIAN M LIPPMAN SM DIMERY IW FRANKENTHALER RA HONG WK
Citation: Mh. Huber et al., PHASE I II STUDY OF CISPLATIN, 5-FLUOROURACIL AND ALPHA-INTERFERON FOR RECURRENT CARCINOMA OF THE HEAD AND NECK/, Investigational new drugs, 12(3), 1994, pp. 223-229

Authors: HUBER MH HONG WK
Citation: Mh. Huber et Wk. Hong, BIOLOGY AND CHEMOPREVENTION OF HEAD AND NECK-CANCER, Current problems in cancer, 18(2), 1994, pp. 83-140

Authors: HUBER MH LIPPMAN SM HONG WK
Citation: Mh. Huber et al., CHEMOPREVENTION OF HEAD AND NECK-CANCER, Seminars in oncology, 21(3), 1994, pp. 366-375

Authors: LEE JS NEWMAN RA LIPPMAN SM HUBER MH MINOR T RABER MN KRAKOFF IH HONG WK
Citation: Js. Lee et al., PHASE-I EVALUATION OF ALL-TRANS-RETINOIC ACID IN ADULTS WITH SOLID TUMORS, Journal of clinical oncology, 11(5), 1993, pp. 959-966

Authors: HUBER MH LEE JS HONG WK
Citation: Mh. Huber et al., CHEMOPREVENTION OF LUNG-CANCER, Seminars in oncology, 20(2), 1993, pp. 128-141
Risultati: 1-12 |